Li Ye, Cui Yue, Hart Steven N, Klaassen Curtis D, Zhong Xiao-bo
Department of Pharmacology, Toxicology, and Therapeutics, The University of Kansas Medical Center, Kansas City, KS 66160, USA.
Mol Pharmacol. 2009 May;75(5):1171-9. doi: 10.1124/mol.108.052993. Epub 2009 Feb 2.
Human cytochrome P450 3A (CYP3A) members are major drug-metabolizing enzymes in the liver. Two genes, CYP3A4 and CYP3A7, exhibit a developmental switch in gene expression during liver maturation. CYP3A4 is mainly expressed in adults, whereas CYP3A7 is dominantly expressed during the fetal and neonatal stages. Their ontogenic expression results in developmentally related changes in the capacity to metabolize endogenous and exogenous compounds. Thus, it is desirable to understand the mechanisms controlling the developmental switch. Mice also exhibit a developmental switch between Cyp3a16 (neonatal isoform) and Cyp3a11 (adult isoform) and may serve as a model to study the mechanisms controlling the developmental switch. Because the epigenetic code (e.g., DNA methylation and histone modifications) is implicated in regulating gene expression and cellular differentiation during development, the current study determined the status of DNA methylation, histone-3-lysine-4 dimethylation (H3K4me2) and histone-3-lysine-27 trimethylation (H3K27me3) around the mouse Cyp3a locus at various developmental ages from prenatal, through neonatal, to young adult. DNA was not hypermethylated in the Cyp3a locus at any age. However, increases in Cyp3a16 expression in neonatal livers and Cyp3a11 in adult livers were associated with increases of H3K4me2. Suppression of Cyp3a16 expression in adult livers coincided with decreases of H3K4me2 and increases of H3K27me3 around Cyp3a16. In conclusion, histone modifications of H3K4me2 and H3K27me3 are dynamically changed in a locus-specific manner along the Cyp3a locus. Developmental switch between Cyp3a11 and Cyp3a16 gene expression seems to be due to dynamic changes of histone modifications during postnatal liver maturation.
人类细胞色素P450 3A(CYP3A)成员是肝脏中主要的药物代谢酶。CYP3A4和CYP3A7这两个基因在肝脏成熟过程中表现出基因表达的发育性转换。CYP3A4主要在成人中表达,而CYP3A7在胎儿期和新生儿期占主导表达。它们的个体发生表达导致代谢内源性和外源性化合物能力的发育相关变化。因此,了解控制这种发育性转换的机制是很有必要的。小鼠在Cyp3a16(新生儿异构体)和Cyp3a11(成人异构体)之间也表现出发育性转换,可作为研究控制发育性转换机制的模型。由于表观遗传密码(如DNA甲基化和组蛋白修饰)参与发育过程中基因表达和细胞分化的调控,本研究确定了从小鼠产前到新生儿期再到年轻成年期不同发育阶段Cyp3a基因座周围的DNA甲基化、组蛋白H3赖氨酸4二甲基化(H3K4me2)和组蛋白H3赖氨酸27三甲基化(H3K27me3)状态。在任何年龄,Cyp3a基因座的DNA都没有发生高甲基化。然而,新生儿肝脏中Cyp3a16表达的增加以及成年肝脏中Cyp3a11表达的增加与H3K4me2的增加相关。成年肝脏中Cyp3a16表达的抑制与Cyp3a16周围H3K4me2的减少和H3K27me3的增加同时发生。总之,H3K4me2和H3K27me3的组蛋白修饰沿着Cyp3a基因座以位点特异性方式动态变化。Cyp3a11和Cyp3a16基因表达之间的发育性转换似乎是由于出生后肝脏成熟过程中组蛋白修饰的动态变化所致。